TB-500 (5mg) Dosage Protocol
TB-500 is a synthetic version of the active region of Thymosin Beta-4, a naturally occurring peptide present in human and animal cells. Research focuses on its role in tissue repair and wound healing.
Add 2.0 mL bacteriostatic water → 2.5 mg/mL (2500 mcg/mL)
Loading: 2-2.5mg twice weekly; Maintenance: 500-1000 mcg weekly
At 2.5 mg/mL: 40 units = 1mg, 20 units = 500 mcg
Lyophilized: -20°C; Reconstituted: 2-8°C for up to 3 weeks
| Week | Daily Dose | Units (per injection) |
|---|---|---|
| Weeks 1-4 (Loading) | 2-2.5mg twice weekly | 80-100 units per dose |
| Weeks 5-8 (Transition) | 1-1.5mg twice weekly | 40-60 units per dose |
| Weeks 9+ (Maintenance) | 500-1000 mcg weekly | 20-40 units weekly |
- 1Draw 2.0 mL bacteriostatic water with a sterile syringe
- 2Inject slowly down the vial wall to prevent foaming
- 3Gently swirl until fully dissolved - do not shake
- 4Label with date and concentration, refrigerate immediately
TB-500 contains the active region of Thymosin Beta-4 responsible for actin binding and cell migration. Research indicates it promotes angiogenesis, supports wound healing, and may reduce inflammation. Clinical trials have evaluated topical formulations at 0.01%-0.1% concentrations for wound healing applications.
- Promotes tissue repair and wound healing
- Supports angiogenesis and blood vessel formation
- May reduce inflammation and scar tissue
- Enhances cellular migration to injury sites
- ClinicalTrials.gov NCT00832091 - Thymosin Beta 4 in Venous Stasis Ulcers
- Sosne G, et al. Thymosin beta 4: A novel wound healing agent. Clin Ophthalmol. 2007
- Davison G, Brown S. Potential use of thymosin β-4 in sport. J Sports Sci. 2013;31(10):1054-60
Lyophilized
Store at -20°C, protected from light
Reconstituted
Refrigerate at 2-8°C, use within 3 weeks
TB-500 is sensitive to temperature; maintain cold chain
- •Research compound - not FDA approved for human use
- •Loading phase is important for tissue saturation
- •Can be injected subcutaneously or intramuscularly
- •Often combined with BPC-157 for synergistic effects
Disclaimer: This content is intended for research and educational purposes only. Not intended to diagnose, treat, cure, or prevent any disease. All compounds are for research use only. Dosing information is derived from published scientific literature and clinical studies.